Variations in conjugation chemistry conditions can lead to differences in stoichiometries and, ultimately, impact drug safety and efficacy. Therefore, there is an urgent need to measure multiple ...

This eBook from ACROBiosystems offers a comprehensive look at the company's end-to-end solution portfolio for antibody-drug conjugate (ADC) development, from early discovery through preclinical and ...

Key opportunities in the protein labeling market include increasing demand for site-specific tags in proteomics and drug development, the rise of AI tools for protein structure prediction, and the ...

Preclinical results indicate new approach could be a way to deliver treatment directly to tumors at higher doses, while reducing side effects in healthy tissue.